NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001928

Registered date:01/05/2009

Phase II trial of preoperatively CDDP/S-1 for patients with clinical stage II(exclusion N0 disease) and Stage IIIA non-small cell lung cancer

Basic Information

Recruitment status
Health condition(s) or Problem(s) studiedNon-small cell lung cancer
Date of first enrollment2008/12/01
Target sample size35
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Preoperatively induction chemotherapy (CDDP/S-1)

Outcome(s)

Primary OutcomeAnalysis of regulation factors from lymph node samples usng EBUS-TBNA and relation to radiological, histological response rate after induction chemotherapy
Secondary Outcomefeasibility, progression free survival, overall survival,and safety

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum75years-old
GenderMale and Female
Include criteria
Exclude criteria1)Patients with severe drug allergy 2)Patients with administration of another 5-fluouracil derivative drugs, flucytosine, phenytoin, warfarin sodium 3)Patients with active concomitant malignancy 4)Patients with active severe infection, diarrhea, interstinalparalysis, ileus, uncontrolled diabetes mellitus, uncontrolled angina, myocardial infarction within 6 months from onset, heart failure, other severe complications 5)Patients with active lung disease such as idopathic pulmonary fibrosis, pulmonary emphysema, severe chronic bronchitis, bronchial asthma 6)Patients with uncontrollable psychiatrical complications

Related Information

Contact

public contact
Name
Address Japan
Telephone
E-mail
Affiliation Graduate School of Medicine, Chiba University Thoracic Surgery
scientific contact
Name Ichiro Yoshino
Address 1-8-1 Inohana, Chuo-ku, Chiba Japan
Telephone
E-mail
Affiliation Graduate School of Medicine, Chiba University Thoracic Surgery